Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Mark Abzug

Concepts (408)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Enterovirus Infections
21
2019
175
2.620
Why?
HIV Infections
27
2022
3210
1.600
Why?
Antiretroviral Therapy, Highly Active
9
2017
278
1.590
Why?
Pneumococcal Vaccines
5
2021
130
1.550
Why?
Antiviral Agents
12
2024
774
1.350
Why?
Pregnancy Complications, Infectious
14
2015
437
1.270
Why?
Enterovirus
9
2019
83
1.110
Why?
Hematopoietic Stem Cell Transplantation
4
2021
700
0.900
Why?
Immunologic Memory
3
2013
369
0.880
Why?
Pneumococcal Infections
3
2013
104
0.860
Why?
Immunization, Secondary
4
2021
93
0.840
Why?
Oxadiazoles
4
2015
33
0.780
Why?
Paralysis
4
2018
69
0.680
Why?
Child
56
2024
22638
0.610
Why?
Triazoles
3
2024
190
0.580
Why?
Sinusitis
7
2013
220
0.550
Why?
Mucositis
1
2018
20
0.540
Why?
Anti-Retroviral Agents
8
2022
250
0.530
Why?
Vaccination
4
2017
1444
0.530
Why?
Meningoencephalitis
1
2017
24
0.520
Why?
Candidiasis, Invasive
3
2024
6
0.510
Why?
Antibodies, Bacterial
4
2013
147
0.510
Why?
Myelitis
4
2019
107
0.500
Why?
Influenza, Human
5
2015
634
0.500
Why?
Theilovirus
4
2000
4
0.490
Why?
Encephalitis
1
2017
142
0.460
Why?
Influenza A Virus, H1N1 Subtype
3
2015
161
0.460
Why?
Graft vs Host Disease
1
2018
280
0.450
Why?
Encephalomyelitis, Acute Disseminated
1
2015
11
0.450
Why?
Neonatal Sepsis
1
2015
9
0.440
Why?
Immunocompromised Host
5
2021
201
0.440
Why?
Central Nervous System Viral Diseases
4
2019
78
0.440
Why?
Herpes Simplex
4
2017
102
0.420
Why?
Influenza Vaccines
3
2015
541
0.420
Why?
Antifungal Agents
5
2024
153
0.420
Why?
Disease Outbreaks
6
2019
420
0.410
Why?
Neuromyelitis Optica
1
2015
135
0.390
Why?
CD4 Lymphocyte Count
8
2022
280
0.390
Why?
Placenta
6
2000
794
0.380
Why?
Adolescent
37
2024
22451
0.370
Why?
Child, Preschool
28
2024
11888
0.370
Why?
Humans
89
2024
145625
0.370
Why?
Drug Discovery
1
2013
153
0.360
Why?
Measles Vaccine
1
2012
19
0.360
Why?
Neuromuscular Diseases
3
2019
146
0.360
Why?
Infant, Newborn
25
2018
6449
0.360
Why?
Infant
27
2024
10093
0.360
Why?
Mucormycosis
3
2005
18
0.360
Why?
RNA, Viral
12
2013
691
0.330
Why?
Meningococcal Vaccines
2
2012
57
0.320
Why?
Cardiovirus Infections
2
2000
3
0.320
Why?
Female
62
2024
79080
0.310
Why?
Male
53
2024
73014
0.310
Why?
Viral Vaccines
2
2009
107
0.310
Why?
Candidemia
2
2023
16
0.310
Why?
Oxazoles
4
2015
48
0.310
Why?
Anti-HIV Agents
5
2022
914
0.300
Why?
Hepatitis B Vaccines
1
2009
43
0.290
Why?
Viral Load
7
2017
525
0.290
Why?
AIDS-Related Opportunistic Infections
3
2015
130
0.290
Why?
Bacterial Vaccines
1
2009
63
0.280
Why?
Fatigue Syndrome, Chronic
1
2008
19
0.270
Why?
Pertussis Vaccine
1
2007
25
0.260
Why?
Communicable Diseases, Emerging
1
2008
39
0.260
Why?
Poliomyelitis
2
1997
35
0.260
Why?
Mycetoma
2
2004
7
0.250
Why?
Immunoglobulins, Intravenous
3
1997
134
0.240
Why?
Rhinitis
3
2009
159
0.240
Why?
Viremia
5
2021
158
0.240
Why?
Fetus
3
2000
798
0.240
Why?
Antibodies, Viral
5
2022
683
0.210
Why?
Pregnancy
16
2021
7217
0.210
Why?
Enterovirus B, Human
3
2001
25
0.210
Why?
Meningitis, Viral
2
2004
19
0.210
Why?
Maxillary Sinusitis
2
2004
6
0.200
Why?
Maus Elberfeld virus
3
1993
5
0.200
Why?
Anti-Bacterial Agents
3
2013
1935
0.200
Why?
Cytomegalovirus
2
2016
169
0.190
Why?
Interferon-gamma
2
2015
780
0.190
Why?
Acquired Immunodeficiency Syndrome
2
2017
237
0.180
Why?
Global Health
2
2018
402
0.180
Why?
Placenta Diseases
2
1995
20
0.180
Why?
Administration, Intravenous
2
2024
172
0.180
Why?
Centralized Hospital Services
1
2001
6
0.180
Why?
Pneumonia, Viral
2
2021
387
0.170
Why?
Hepatitis, Viral, Human
1
2001
21
0.170
Why?
Oseltamivir
2
2012
17
0.170
Why?
Fetal Diseases
3
2000
192
0.170
Why?
Research Support as Topic
1
2001
81
0.170
Why?
Colorado
7
2021
4588
0.160
Why?
United States
13
2021
16041
0.150
Why?
Ethmoid Sinusitis
1
1999
1
0.150
Why?
Hydrops Fetalis
1
1999
13
0.150
Why?
Streptococcus pneumoniae
3
2014
187
0.150
Why?
Uterine Diseases
1
1999
18
0.150
Why?
Retrospective Studies
14
2022
17291
0.150
Why?
Intracranial Hemorrhages
1
2000
106
0.150
Why?
Polymerase Chain Reaction
4
2016
1030
0.150
Why?
Embryonic Development
1
2000
124
0.150
Why?
Drug Resistance, Microbial
1
1999
67
0.140
Why?
Blood Coagulation Disorders
1
2001
190
0.140
Why?
Antibodies, Neutralizing
3
2022
346
0.140
Why?
Mastoiditis
2
2014
10
0.140
Why?
Biliary Atresia
1
2020
161
0.140
Why?
Young Adult
14
2017
14240
0.140
Why?
Treatment Outcome
10
2024
11744
0.140
Why?
Follow-Up Studies
8
2022
5397
0.140
Why?
Nervous System Diseases
2
2019
286
0.140
Why?
Enterovirus D, Human
2
2018
89
0.140
Why?
Heptavalent Pneumococcal Conjugate Vaccine
2
2009
14
0.140
Why?
Fluoxetine
1
2018
56
0.140
Why?
Risk Factors
12
2024
10840
0.140
Why?
Enzyme-Linked Immunosorbent Assay
2
2013
845
0.140
Why?
Arboviruses
1
2017
14
0.130
Why?
Hospitals, Pediatric
1
2001
561
0.130
Why?
Neurodevelopmental Disorders
1
2021
234
0.130
Why?
Nucleic Acid Hybridization
6
1991
175
0.130
Why?
In Situ Hybridization
4
2000
317
0.130
Why?
Double-Blind Method
3
2015
2064
0.130
Why?
Acyclovir
2
2015
97
0.130
Why?
Disease Transmission, Infectious
1
2018
69
0.130
Why?
HIV-1
2
2015
911
0.130
Why?
Allografts
1
2018
148
0.130
Why?
Antibodies, Monoclonal
2
2022
1511
0.130
Why?
Sexual Maturation
1
2017
49
0.130
Why?
Cohort Studies
7
2024
6045
0.130
Why?
Endoscopy
1
1999
316
0.120
Why?
Immunization, Passive
1
1997
90
0.120
Why?
Practice Guidelines as Topic
2
2022
1581
0.120
Why?
Cytomegalovirus Retinitis
1
2016
22
0.120
Why?
Clinical Trials as Topic
1
2001
1062
0.120
Why?
Brain
3
2017
2981
0.120
Why?
Adoption
1
2016
25
0.120
Why?
Hyperlipidemias
1
2017
120
0.120
Why?
DNA, Viral
2
2016
352
0.120
Why?
Gastrointestinal Diseases
1
2018
220
0.110
Why?
Mice, Inbred ICR
4
1997
103
0.110
Why?
Nasal Mucosa
2
2009
112
0.110
Why?
Diagnosis, Differential
2
2017
1500
0.110
Why?
Congenital Abnormalities
2
2010
108
0.110
Why?
Lymphocyte Subsets
1
2015
79
0.110
Why?
Sexually Transmitted Diseases
1
2017
163
0.110
Why?
Respiratory Syncytial Virus Infections
1
1997
139
0.110
Why?
Postoperative Complications
2
2016
2962
0.110
Why?
Chi-Square Distribution
2
2013
511
0.110
Why?
Ganciclovir
1
2015
51
0.110
Why?
Child Development
2
2017
481
0.110
Why?
Muscle Hypotonia
1
2015
34
0.110
Why?
Lymphopenia
1
2015
62
0.110
Why?
Oropharynx
1
2015
46
0.110
Why?
Cranial Nerve Diseases
1
2015
42
0.110
Why?
Adenovirus Infections, Human
2
1991
15
0.110
Why?
Incidence
6
2017
2910
0.100
Why?
Hearing Loss, Sensorineural
1
2015
66
0.100
Why?
Adult
17
2022
40821
0.100
Why?
Beclomethasone
1
1993
8
0.100
Why?
Controlled Clinical Trials as Topic
1
2013
26
0.100
Why?
Liver Transplantation
1
2020
699
0.100
Why?
Puberty, Delayed
1
2013
10
0.100
Why?
Rectum
1
2015
180
0.100
Why?
Mycoses
1
2014
86
0.100
Why?
Antibody Affinity
1
2013
60
0.100
Why?
Giant Cells
1
1993
21
0.100
Why?
Hemagglutination Inhibition Tests
1
2013
38
0.100
Why?
Cytomegalovirus Infections
1
2015
203
0.090
Why?
Chickenpox
1
1993
83
0.090
Why?
Candida
1
2012
46
0.090
Why?
Viral Plaque Assay
1
2012
29
0.090
Why?
Hospital Design and Construction
1
1992
3
0.090
Why?
Intensive Care Units, Pediatric
1
2015
293
0.090
Why?
Orthomyxoviridae
1
2012
41
0.090
Why?
Neutralization Tests
1
2012
74
0.090
Why?
Aircraft
1
1992
21
0.090
Why?
CD4-Positive T-Lymphocytes
2
2017
1148
0.090
Why?
Bacterial Infections
2
2009
246
0.090
Why?
Ureaplasma urealyticum
1
1991
3
0.090
Why?
HIV
1
2013
249
0.090
Why?
Severity of Illness Index
4
2021
2910
0.090
Why?
Drug Resistance, Viral
1
2012
126
0.090
Why?
Chlamydia trachomatis
1
1991
49
0.090
Why?
Gestational Age
4
2015
989
0.080
Why?
Chorioamnionitis
1
1991
50
0.080
Why?
Peritoneovenous Shunt
1
1990
1
0.080
Why?
Maternal-Fetal Exchange
2
2007
171
0.080
Why?
Meningitis, Aseptic
1
1990
13
0.080
Why?
Poliovirus Vaccine, Oral
1
1990
25
0.080
Why?
Decision Support Techniques
1
2015
473
0.080
Why?
Trophoblasts
1
1993
219
0.080
Why?
Rimantadine
1
2010
1
0.080
Why?
Prospective Studies
7
2017
8087
0.080
Why?
Legionnaires' Disease
1
1990
4
0.080
Why?
Adamantane
1
2010
18
0.080
Why?
Poliovirus
1
1990
73
0.080
Why?
Hepatitis B Antibodies
1
2009
6
0.080
Why?
Biomarkers
1
2021
4329
0.080
Why?
Cross Infection
1
1992
258
0.070
Why?
Meningitis
1
1990
80
0.070
Why?
T-Lymphocytes
2
2015
2007
0.070
Why?
Respiratory Tract Infections
3
2016
399
0.070
Why?
Administration, Oral
3
2012
867
0.070
Why?
Maxillary Sinus
2
2009
11
0.070
Why?
Mice
8
2000
18266
0.070
Why?
Age Factors
4
2017
3321
0.070
Why?
Mucor
2
2005
6
0.070
Why?
South Africa
1
2009
262
0.070
Why?
Evidence-Based Medicine
3
2021
727
0.070
Why?
Drug Administration Schedule
2
2015
782
0.060
Why?
Body Fluids
1
1987
70
0.060
Why?
Reverse Transcriptase Inhibitors
1
2007
88
0.060
Why?
Acute Kidney Injury
1
2015
861
0.060
Why?
Aspergillosis
2
2014
24
0.060
Why?
Virus Diseases
1
2009
219
0.060
Why?
Mitochondrial Diseases
1
2007
94
0.060
Why?
Zygomycosis
1
2006
6
0.060
Why?
Carotid Artery Thrombosis
1
2005
6
0.060
Why?
Organ Transplantation
1
2009
235
0.060
Why?
Statistics as Topic
1
2006
277
0.060
Why?
Chronic Disease
5
2009
1824
0.060
Why?
Logistic Models
2
2023
2112
0.060
Why?
Antibodies, Monoclonal, Humanized
2
2022
992
0.060
Why?
Drug Therapy, Combination
2
2007
1034
0.060
Why?
International Cooperation
2
2018
192
0.050
Why?
Scedosporium
1
2004
1
0.050
Why?
Herpesvirus 7, Human
1
2004
6
0.050
Why?
Drug Resistance, Fungal
1
2004
8
0.050
Why?
Roseolovirus Infections
1
2004
8
0.050
Why?
Herpesvirus 6, Human
1
2004
14
0.050
Why?
Animals
9
2000
38030
0.050
Why?
Longitudinal Studies
3
2018
3005
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2004
90
0.050
Why?
Respiratory Syncytial Viruses
2
1997
58
0.050
Why?
Randomized Controlled Trials as Topic
2
2004
1754
0.050
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2004
158
0.050
Why?
Vaccines, Conjugate
2
2014
60
0.050
Why?
Infant, Premature, Diseases
2
1997
113
0.050
Why?
Biological Availability
1
2003
146
0.050
Why?
Probability
1
2003
308
0.040
Why?
Risk Assessment
2
2020
3678
0.040
Why?
Growth Disorders
1
2022
88
0.040
Why?
Reference Values
1
2003
787
0.040
Why?
Bacteria, Aerobic
1
2001
7
0.040
Why?
Case-Control Studies
3
2015
3633
0.040
Why?
Personnel Staffing and Scheduling
1
2001
100
0.040
Why?
Disease Models, Animal
3
2000
4565
0.040
Why?
Drug Combinations
1
2022
399
0.040
Why?
Drug Approval
1
2021
93
0.040
Why?
Income
1
2022
205
0.040
Why?
RNA Probes
2
1991
11
0.040
Why?
Prenatal Exposure Delayed Effects
1
2007
662
0.040
Why?
Disseminated Intravascular Coagulation
1
2000
34
0.040
Why?
United States Food and Drug Administration
1
2021
207
0.040
Why?
RNA
2
2022
925
0.040
Why?
Systemic Inflammatory Response Syndrome
1
2021
96
0.040
Why?
Adenosine Monophosphate
1
2021
87
0.040
Why?
Alanine
1
2021
171
0.040
Why?
Fungi
2
2014
120
0.040
Why?
Necrosis
1
2000
243
0.040
Why?
Remission Induction
1
2020
308
0.040
Why?
Picornaviridae Infections
2
1990
53
0.040
Why?
Otitis Media with Effusion
1
1999
20
0.040
Why?
Amniotic Fluid
2
1991
75
0.040
Why?
Cerebrospinal Fluid
2
2004
88
0.040
Why?
Pharyngitis
1
1999
28
0.040
Why?
Pseudallescheria
1
1999
3
0.040
Why?
Living Donors
1
2020
205
0.040
Why?
Zidovudine
2
2010
75
0.040
Why?
Opportunistic Infections
1
1999
47
0.030
Why?
Dose-Response Relationship, Drug
1
2003
2018
0.030
Why?
Time Factors
1
2009
7079
0.030
Why?
Spinal Cord
1
2000
378
0.030
Why?
Diabetes Mellitus, Type 1
2
2005
3930
0.030
Why?
Chlamydiaceae Infections
1
2017
1
0.030
Why?
Epidemiological Monitoring
1
2018
70
0.030
Why?
Nutrition Disorders
1
1997
20
0.030
Why?
Internationality
1
2018
156
0.030
Why?
Sex Factors
2
2017
2101
0.030
Why?
B-Lymphocytes
2
2015
884
0.030
Why?
Abortion, Spontaneous
1
1997
119
0.030
Why?
Ophthalmoscopy
1
2016
38
0.030
Why?
Heart
1
2000
624
0.030
Why?
Tissue and Organ Procurement
1
2020
298
0.030
Why?
Antigens, Viral
1
2017
186
0.030
Why?
Otitis Media
1
1999
178
0.030
Why?
Reoperation
1
1999
633
0.030
Why?
Encephalomyelitis
1
2016
14
0.030
Why?
Plasma Cells
2
2009
80
0.030
Why?
Acute Disease
1
1999
1033
0.030
Why?
Enzyme-Linked Immunospot Assay
1
2015
40
0.030
Why?
Immune Tolerance
2
1999
384
0.030
Why?
AIDS Dementia Complex
1
2015
49
0.030
Why?
Molecular Diagnostic Techniques
1
2016
104
0.030
Why?
North America
1
2016
299
0.030
Why?
Caribbean Region
1
2015
29
0.030
Why?
Transplantation, Homologous
1
2016
415
0.030
Why?
Multicenter Studies as Topic
1
1997
413
0.030
Why?
Encephalitis, Varicella Zoster
1
2015
17
0.030
Why?
Biopsy
3
2009
1073
0.030
Why?
Encephalitis, Herpes Simplex
1
2015
21
0.030
Why?
Patient Outcome Assessment
1
2016
128
0.030
Why?
Audiometry
1
2015
34
0.030
Why?
Physical Conditioning, Animal
1
1997
242
0.030
Why?
Evaluation Studies as Topic
1
1995
160
0.030
Why?
Latin America
1
2015
96
0.030
Why?
Malnutrition
1
2016
86
0.030
Why?
Odds Ratio
1
2017
1070
0.030
Why?
Microscopy, Electron
1
1995
384
0.030
Why?
Coinfection
1
2016
143
0.030
Why?
C-Reactive Protein
1
2017
427
0.030
Why?
Hematologic Neoplasms
1
2016
169
0.030
Why?
Canada
1
2015
430
0.030
Why?
Combined Modality Therapy
3
2005
1269
0.030
Why?
Evoked Potentials, Auditory, Brain Stem
1
2015
53
0.030
Why?
Neutropenia
1
2015
153
0.030
Why?
Metabolic Diseases
1
2015
114
0.030
Why?
Infusions, Intravenous
1
2015
429
0.020
Why?
Multivariate Analysis
1
2017
1531
0.020
Why?
Papillomavirus Vaccines
1
2017
296
0.020
Why?
Administration, Intranasal
1
1993
94
0.020
Why?
Sequence Analysis, DNA
1
2016
771
0.020
Why?
Sexual Behavior
1
2017
489
0.020
Why?
Papillomavirus Infections
1
2017
345
0.020
Why?
T-Lymphocyte Subsets
1
2015
415
0.020
Why?
Mortality
1
2015
375
0.020
Why?
Epidemiologic Studies
1
2012
70
0.020
Why?
Pandemics
1
2021
1700
0.020
Why?
Oncology Service, Hospital
1
1992
15
0.020
Why?
Prognosis
1
2001
4331
0.020
Why?
Electromyography
1
2015
417
0.020
Why?
Neisseria meningitidis
1
2012
23
0.020
Why?
Meningococcal Infections
1
2012
26
0.020
Why?
Infant, Premature
1
1997
622
0.020
Why?
Tomography, X-Ray Computed
2
1999
2766
0.020
Why?
Ureaplasma Infections
1
1991
3
0.020
Why?
Ventilation
1
1992
44
0.020
Why?
Amniocentesis
1
1991
20
0.020
Why?
Mycoplasma Infections
1
1991
17
0.020
Why?
Microbial Viability
1
2012
82
0.020
Why?
Europe
1
2012
420
0.020
Why?
Flow Cytometry
1
2015
1160
0.020
Why?
Adenoviruses, Human
1
1991
26
0.020
Why?
Hospitals, University
1
1991
176
0.020
Why?
Lymphocyte Activation
1
2015
1136
0.020
Why?
Respirovirus Infections
1
1990
14
0.020
Why?
Anti-Infective Agents
1
2013
234
0.020
Why?
Comorbidity
1
2016
1652
0.020
Why?
Paramyxoviridae Infections
1
1990
13
0.020
Why?
Aged, 80 and over
1
2023
8351
0.020
Why?
Immunohistochemistry
1
1995
1709
0.020
Why?
Chlamydia Infections
1
1991
79
0.020
Why?
Benzoxazines
1
2010
31
0.020
Why?
Rhinovirus
1
1990
60
0.020
Why?
Cyclopropanes
1
2010
83
0.020
Why?
Legionella
1
1990
9
0.020
Why?
Alkynes
1
2010
67
0.020
Why?
Population Surveillance
1
1993
477
0.020
Why?
Cells, Cultured
1
1997
4112
0.020
Why?
Sensitivity and Specificity
1
1995
1992
0.020
Why?
Leukemia
1
1992
246
0.020
Why?
Inpatients
1
2014
538
0.020
Why?
Dermatomyositis
1
1989
24
0.020
Why?
Hospitals
1
2014
730
0.020
Why?
Peroxidase
1
2009
168
0.020
Why?
Staining and Labeling
1
2009
148
0.020
Why?
Muscles
1
1989
330
0.020
Why?
Natural Killer T-Cells
1
2009
71
0.020
Why?
Respiratory Tract Diseases
1
1990
178
0.020
Why?
Magnetic Resonance Imaging
2
2015
3917
0.020
Why?
Picornaviridae
1
1988
18
0.020
Why?
Seasons
1
1990
535
0.020
Why?
Ribonucleases
1
1987
49
0.020
Why?
Central Nervous System
1
2010
278
0.020
Why?
HIV Reverse Transcriptase
1
2007
32
0.020
Why?
Lamivudine
1
2007
63
0.020
Why?
Telencephalon
1
2005
16
0.010
Why?
Cavernous Sinus
1
2005
16
0.010
Why?
Antigens, CD
1
2009
559
0.010
Why?
Orbit
1
2005
67
0.010
Why?
Infectious Disease Transmission, Vertical
1
2007
188
0.010
Why?
Paranasal Sinuses
1
2005
77
0.010
Why?
Cross-Sectional Studies
1
2016
5875
0.010
Why?
Exocrine Glands
1
2004
5
0.010
Why?
Basement Membrane
1
2004
32
0.010
Why?
Cell Count
1
2004
315
0.010
Why?
Prevalence
1
2010
2852
0.010
Why?
Neutrophils
1
2009
1132
0.010
Why?
Lymphocytes
1
2004
379
0.010
Why?
Eosinophils
1
2004
319
0.010
Why?
Penicillin Resistance
1
2001
9
0.010
Why?
Staphylococcus
1
2001
74
0.010
Why?
Macrophages
1
2009
1530
0.010
Why?
beta-Lactamases
1
2001
54
0.010
Why?
Drug Resistance, Multiple, Bacterial
1
2001
77
0.010
Why?
Haemophilus influenzae
1
2001
67
0.010
Why?
Drug Resistance, Bacterial
1
2001
185
0.010
Why?
Nasal Decongestants
1
1999
9
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
1999
38
0.010
Why?
Steroids
1
1999
160
0.010
Why?
Recurrence
1
1999
1125
0.010
Why?
Anti-Inflammatory Agents
1
1999
473
0.010
Why?
Patient Selection
1
1999
720
0.010
Why?
RNA, Antisense
1
1988
18
0.000
Why?
DNA, Recombinant
1
1988
46
0.000
Why?
Sequence Homology, Nucleic Acid
1
1988
157
0.000
Why?
Virus Replication
1
1988
525
0.000
Why?
Aged
1
2006
26251
0.000
Why?
Middle Aged
1
2006
36359
0.000
Why?
Cell Line
1
1988
2809
0.000
Why?
DNA
1
1988
1418
0.000
Why?
Abzug's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)